Vijay Welle

Bachelor of Medicine and Bachelor of Science,  Massachusetts General Hospital 

Location: Germany

Consulting Services

Career Advice and Mentoring Biostatistics Data Science-Bioinformatics Scientific Writing Research Consulting

Areas Of Interest

Volume, Cell Food Handling Rectum Cancer Domains, Kringle Sensory Neuropathy, Hereditary Chili Pepper c-vav, Proto-Oncogene Proteins Apir Levulosa Facial Dysplasia, Lateral Mycobacterium avium paratuberculosis Bisphosphonate Osteonecroses Bosentan NADH Dependent Enoyl ACP Reductase Anisakiasis Hydrogen Deuterium Exchange Measurement Streptogramin B Fibroblast Growth Factor Receptor-5 Glucoamylase Icelandic Type Amyloidosis Gastrectomies Cognitive Ergonomic Secretin Cell, Intestinal Projections and Predictions Stenosing Tenosynovitides Pre-Authorizations Remoxipride Hydrochloride Limitation, Mobility Genetic Counseling Tabebuia rosea Structure Collapses IKK 1 Kinase Tetanies Diptera Clioquinol Evaluation Studies, FDA Phase I Antecedent, Plasma Thromboplastin Cycles, Futile Substrate Joints, Arthrocentesis,Temporomandibular

Professional Narrative

Dr. Vijay Welle was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Welle has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Medical Writer, Mayo Clinic 2019
Assistant Professor, Harvard Med 2004

Education

Doctor of medicine, Harvard Medical School 1989
Director Medicine, Harvard Medical School 2005

Referees


Publications

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :